Luying Geng

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Chemotherapy Induced

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Panpan Jiang, Luying Geng, Ziyang Mao, Qinyang Wang, Wenjuan Wang, Min Jiao, Na Liu, Nanzheng Chen, Jia Zhang, Kejun Nan, Yuan Shen, Hui Guo, Lili Jiang
First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions. Immunotherapy (2022)